Erasmus School of Health Policy & Management
Visiting fellow | Health Economics (HE)
- l.timmers@eshpm.eur.nl
More information
Work
- Anne Willemsen, Maureen van Molken, Riam al Dulaimi, Hedi Schelleman, Wim G. Goettsch & Lonneke Timmers (2025) - Preparing for the EU HTA Regulation: Insights from the Dutch Perspective - Journal of Market Access and Health Policy, 13 (3) - doi: 10.3390/jmahp13030035
- Sibren van den Berg, Carolina E. Hollak, Lonneke Timmers & Samuel J. de Visser (2025) - Twenty-Four Years After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars, and Generics for Orphan Medicinal Products - Value in Health, 28 (5), 692-698 - doi: 10.1016/j.jval.2025.03.004 - [link]
- Michiel Zietse, Roelof W.F. van Leeuwen, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Jolanda E. de Boer, Rudy Dupree, Ron H.J. Mathijssen & Lonneke Timmers (2024) - Interchangeability of immune checkpoint inhibitors: an urgent need for action - The Lancet Oncology, 25 (11), e611-e616 - doi: 10.1016/S1470-2045(24)00212-2 - [link]
